RVTY
REVVITY, INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$143.45
−2.24%Forward multiples
Based on analyst estimates
- P/E forward
- 25.42x
- P/E 2026E
- 26.95x
- P/E 2027E
- 24.52x
- P/E 2028E
- 22.27x
- P/S forward
- 5.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- 68.31x
- PEG TTM
- 0.41x
- Price / book
- 2.21x
- Price / sales
- 5.50x
- Price / cash flow
- 25.45x
Enterprise value
- Enterprise value
- $18.3B
- EV / sales
- 6.29x
- EV / EBITDA
- 23.89x
- EV / EBIT
- 51.07x
- Market cap
- $16.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026